Max Healthcare Institute Limited reported robust growth for the quarter and year ended March 31, 2026. The Board approved a final dividend of ₹2 per share (20% of face value). Additionally, the company announced the construction of a new 712-bed hospital in Lucknow, reflecting a total investment of ₹1,400 crore. The Board also approved the re-classification of the Radiant Life Care Hospital Foundation from the promoter group to the public category.
Financial Performance Overview
For the financial year ended March 31, 2026, Max Healthcare reported strong financial results. The consolidated revenue from operations reached ₹8,37,345 lakh, with a total net profit of ₹1,44,241 lakh. For the final quarter (Q4) ending March 31, 2026, the company recorded consolidated revenue of ₹2,14,289 lakh and a net profit of ₹34,222 lakh. Reflecting this performance, the Board has recommended a final dividend of ₹2 per equity share, subject to approval at the forthcoming Annual General Meeting.
Strategic Infrastructure Expansion
To bolster its presence in Northern India, the company has approved the construction of Phase-I of a new Max Super Specialty Hospital in Lucknow. Situated on a 5-acre land parcel at Shaheed Path, this facility will add ~712 beds to the network’s capacity. The project involves an investment of approximately ₹1,400 crore, with completion expected within 36 months of drawing approvals. This expansion aims to address the high occupancy levels currently observed across the network’s existing hospitals.
Corporate Updates and Leadership
The Board of Directors has initiated several key corporate governance actions, including the re-classification of Radiant Life Care Hospital Foundation from the ‘Promoter Group’ to the ‘Public’ category. Furthermore, the company will shift its registered office from the State of Maharashtra to the State of Haryana. Additionally, the Board approved the re-appointment of Mr. Anil Kumar Bhatnagar as a Non-Executive and Non-Independent Director for a three-year term, effective from October 1, 2026, through September 30, 2029.
Operational Milestones
The company continues to optimize its administrative operations, including the re-appointment of M/s. Chandra Wadhwa & Co. as Cost Auditors for the 2026-27 financial year. These strategic moves, alongside the recent 58.28% equity stake acquisition in Kalinga Hospitals Limited, underscore the company’s commitment to scaling its healthcare footprint and delivering long-term value to shareholders.
Source: BSE
